ReShape Lifesciences Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
ReShape Lifesciences Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • ReShape Lifesciences Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $27K, a 69% decline year-over-year.
  • ReShape Lifesciences Inc. annual Operating Lease, Payments for 2023 was $228K, a 59.3% decline from 2022.
  • ReShape Lifesciences Inc. annual Operating Lease, Payments for 2022 was $560K, a 0.89% decline from 2021.
  • ReShape Lifesciences Inc. annual Operating Lease, Payments for 2021 was $565K, a 183% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $228K -$332K -59.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $560K -$5K -0.89% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $565K +$365K +183% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $200K -$300K -60% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-12
2019 $500K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.